Phase II biomarker analysis of sorafenib (BAY 43-9006) in patients with advanced hepatocellular carcinoma Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Schwartz, L.; Ricci, S.; Amadori, D.; Santoro, A.; Figer, A.; de Greve, J.; Douillard, J. Y.; Taylor, I.; Moscovici, M.; Bigwood, D.; Voliotis, D.; Saltz, L. B. |
| Abstract Title: | Phase II biomarker analysis of sorafenib (BAY 43-9006) in patients with advanced hepatocellular carcinoma |
| Meeting Title: | AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics |
| Journal Title: | Clinical Cancer Research |
| Volume: | 11 |
| Issue: | 24 Pt. 2 |
| Meeting Dates: | 2005 Nov 14-18 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2005-12-01 |
| Start Page: | 9033s |
| Language: | English |
| ACCESSION: | WOS:000234382700278 |
| PROVIDER: | wos |
| PUBMED: | 16389691 |
| Notes: | Meeting Abstract: B5 -- "Source: Wos" |
